The Angiotensin II AT2Receptor Is an AT1Receptor Antagonist

Journal of Biological Chemistry- United States

doi 10.1074/jbc.m105253200

Full Text

Abstract

Available in

Date

Authors

Publisher

American Society for Biochemistry & Molecular Biology (ASBMB)

Related search

Azilsartan Medoxomil, an Angiotensin II Receptor Antagonist for the Treatment of Hypertension

Basic and Clinical Pharmacology and Toxicology
MedicineToxicologyPharmacology
2017English

Action of AT1receptor Antagonists on Angiotensin II-induced Tone in Human Isolated Subcutaneous Resistance Arteries

British Journal of Pharmacology
Pharmacology
1999English

Angiotensin II Antagonist Prevents Electrical Remodeling in Atrial Fibrillation

Circulation
Cardiovascular MedicinePhysiologyCardiology
2000English

Renal Hemodynamic and Hormonal Responses to the Angiotensin II Antagonist Candesartan

Hypertension
Internal Medicine
2000English

Long-Term Consequences of Fetal Angiotensin II Receptor Antagonist Exposure

Case Reports in Pediatrics
2018English

Jak2 Acts as Both a STAT1 Kinase and as a Molecular Bridge Linking STAT1 to the Angiotensin II AT1Receptor

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2000English

Contribution of Angiotensin Converting Enzyme Gene Polymorphism to the Action of Angiotensin II Receptor Antagonist (CS-866).

Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
2002English

Reduction of Bleomycin Induced Lung Fibrosis by Candesartan Cilexetil, an Angiotensin II Type 1 Receptor Antagonist

Thorax
PulmonaryRespiratory Medicine
2004English

Hemodynamics of a New Angiotensin Antagonist, [Sar1, Thr8]A II, in Hypertensive Man

Circulation
Cardiovascular MedicinePhysiologyCardiology
1980English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy